UBS AM’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56 Buy
+24
New +$59 ﹤0.01% 4235

Other funds holding STIM

UBS AM's STIM Position: Q3 2026 in Review

UBS AM opened a new position in Neuronetics (STIM) in Q3 2026: 24 shares worth $56. The stake represents ﹤0.01% of the portfolio and ranks #4235 among its holdings.

71 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

  • UBS AM held 24 shares of Neuronetics worth $56 as of Q3 2026.
  • Neuronetics was a new UBS AM position in Q3 2026.
  • Neuronetics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4235 holding.
  • 71 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.